Allworth Financial
FHTX icon

Allworth Financial’s Foghorn Therapeutics FHTX Stock Holding History

Allworth Financial’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17K Buy
240
+143
+147% +$635 ﹤0.01% 4671
2026
Q1 		$464 Buy
+97
New +$533 ﹤0.01% 4747

Other funds holding FHTX

Flagship Pioneering
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Allworth Financial's FHTX Position: Q2 2026 in Review

Allworth Financial increased its Foghorn Therapeutics (FHTX) stake by 147% in Q2 2026, buying an estimated $635 and bringing the position to 240 shares worth $1.17K. The position accounts for ﹤0.01% of the portfolio, ranked #4671.

Allworth Financial first reported a position in FHTX in Q1 2026 and has held it in 2 quarters since. 102 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • Allworth Financial held 240 shares of Foghorn Therapeutics worth $1.17K as of Q2 2026.
  • Allworth Financial bought 143 Foghorn Therapeutics shares in Q2 2026, an estimated $635.
  • Foghorn Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4671 holding.
  • Allworth Financial first reported a position in Foghorn Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 102 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.